Who was studied, and how
Four numbers in the abstract
Where each one falls
Where it lands on the map
7,196people with cardiovascular disease, in this paper
Among moderate CKD, the trial randomly assignedassigned by chance
pravastatin
diet alone
Reported lower CHD, no range given−48.0
Reported higher stroke, no range given73×
Reported higher CVD, no range given55×
randomisedthe abstract, start to end
… pravastatin significantly reduced CHD by 48% (P=0.02), stroke by 73% (P<0.01), CVD by 55% (P<0.01), and total mortality by 51% (P=0.02).
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
CHDpravastatin vs diet alone, in moderate CKD
−48.0
Strokepravastatin vs diet alone, in moderate CKD
RR 73
CVDpravastatin vs diet alone, in moderate CKD
RR 55
Total mortalitypravastatin vs diet alone, in moderate CKD
RR 51
StatinsCardiovascular eventsAll-cause mortality
1 / 4